Targeting PIM kinases to oppose hypoxia-mediated therapeutic resistance
Oncoscience
.
2018 Aug 22;5(9-10):254-255.
doi: 10.18632/oncoscience.458.
eCollection 2018 Sep.
Authors
Shailender S Chauhan
1
,
Noel A Warfel
1
Affiliation
1
University of Arizona Cancer Center, Department of Cellular and Molecular Medicine, University of Arizona, Levy Cancer Center, Tucson, Arizona 85724 USA.
PMID:
30460324
PMCID:
PMC6231444
DOI:
10.18632/oncoscience.458
No abstract available
Keywords:
Nrf2; PIM kinase; angiogenesis; hypoxia; therapeutic resistance.